178 related articles for article (PubMed ID: 15725345)
1. CNS activity of Pokeweed anti-viral protein (PAP) in mice infected with lymphocytic choriomeningitis virus (LCMV).
Uckun FM; Rustamova L; Vassilev AO; Tibbles HE; Petkevich AS
BMC Infect Dis; 2005 Feb; 5():9. PubMed ID: 15725345
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models.
Audigé A; Hofer U; Dittmer U; van den Broek M; Speck RF
Viral Immunol; 2011 Oct; 24(5):375-85. PubMed ID: 21929334
[TBL] [Abstract][Full Text] [Related]
3. Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1.
Rajamohan F; Venkatachalam TK; Irvin JD; Uckun FM
Biochem Biophys Res Commun; 1999 Jul; 260(2):453-8. PubMed ID: 10403789
[TBL] [Abstract][Full Text] [Related]
4. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
[TBL] [Abstract][Full Text] [Related]
5. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
6. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
7. Deguanylation of human immunodeficiency virus (HIV-1) RNA by recombinant pokeweed antiviral protein.
Rajamohan F; Kurinov IV; Venkatachalam TK; Uckun FM
Biochem Biophys Res Commun; 1999 Sep; 263(2):419-24. PubMed ID: 10491308
[TBL] [Abstract][Full Text] [Related]
8. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
[TBL] [Abstract][Full Text] [Related]
9. Vaccination to treat persistent viral infection.
von Herrath MG; Berger DP; Homann D; Tishon T; Sette A; Oldstone MB
Virology; 2000 Mar; 268(2):411-9. PubMed ID: 10704349
[TBL] [Abstract][Full Text] [Related]
10. [Effects of pokeweed antiviral protein on nephrotoxic serum nephritis accelerated by rabbit IgG in mice].
Zhu Q; Li XD; Shi GX
Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):474-7. PubMed ID: 3218543
[No Abstract] [Full Text] [Related]
11. Characterization of Mirabilis antiviral protein--a ribosome inactivating protein from Mirabilis jalapa L.
Wong RN; Ng TB; Chan SH; Dong TX; Yeung HW
Biochem Int; 1992 Dec; 28(4):585-93. PubMed ID: 1482397
[TBL] [Abstract][Full Text] [Related]
12. Actions of pokeweed antiviral protein on virus-infected protoplasts.
Watanabe K; Kawasaki T; Sako N; Funatsu G
Biosci Biotechnol Biochem; 1997 Jun; 61(6):994-7. PubMed ID: 9214760
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein.
Ishag HZ; Li C; Huang L; Sun MX; Ni B; Guo CX; Mao X
Virus Res; 2013 Jan; 171(1):89-96. PubMed ID: 23142554
[TBL] [Abstract][Full Text] [Related]
14. Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus.
Uckun FM; Bellomy K; O'Neill K; Messinger Y; Johnson T; Chen CL
J Pharmacol Exp Ther; 1999 Dec; 291(3):1301-7. PubMed ID: 10565855
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of pokeweed antiviral protein.
Aron GM; Irvin JD
Cytobios; 1988; 55(221):105-11. PubMed ID: 3229145
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of TP3(anti-p80)-pokeweed antiviral protein immunotoxin in hamster cheek pouch and severe combined immunodeficient mouse xenograft models of human osteosarcoma.
Ek O; Waurzyniak B; Myers DE; Uckun FM
Clin Cancer Res; 1998 Jul; 4(7):1641-7. PubMed ID: 9676838
[TBL] [Abstract][Full Text] [Related]
17. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077
[TBL] [Abstract][Full Text] [Related]
19. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection.
Buchmeier MJ; Oldstone MB
J Immunol; 1978 Apr; 120(4):1297-304. PubMed ID: 76662
[TBL] [Abstract][Full Text] [Related]
20. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
